Bioengineering & Translational Medicine (Mar 2023)

SERS spectroscopy with machine learning to analyze human plasma derived sEVs for coronary artery disease diagnosis and prognosis

  • Xi Huang,
  • Bo Liu,
  • Shenghan Guo,
  • Weihong Guo,
  • Ke Liao,
  • Guoku Hu,
  • Wen Shi,
  • Mitchell Kuss,
  • Michael J. Duryee,
  • Daniel R. Anderson,
  • Yongfeng Lu,
  • Bin Duan

DOI
https://doi.org/10.1002/btm2.10420
Journal volume & issue
Vol. 8, no. 2
pp. n/a – n/a

Abstract

Read online

Abstract Coronary artery disease (CAD) is one of the major cardiovascular diseases and represents the leading causes of global mortality. Developing new diagnostic and therapeutic approaches for CAD treatment are critically needed, especially for an early accurate CAD detection and further timely intervention. In this study, we successfully isolated human plasma small extracellular vesicles (sEVs) from four stages of CAD patients, that is, healthy control, stable plaque, non‐ST‐elevation myocardial infarction, and ST‐elevation myocardial infarction. Surface‐enhanced Raman scattering (SERS) measurement in conjunction with five machine learning approaches, including Quadratic Discriminant Analysis, Support Vector Machine (SVM), K‐Nearest Neighbor, Artificial Neural network, were then applied for the classification and prediction of the sEV samples. Among these five approaches, the overall accuracy of SVM shows the best predication results on both early CAD detection (86.4%) and overall prediction (92.3%). SVM also possesses the highest sensitivity (97.69%) and specificity (95.7%). Thus, our study demonstrates a promising strategy for noninvasive, safe, and high accurate diagnosis for CAD early detection.

Keywords